A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Novartis researchers use automation to rapidly identify starting points for new drugs.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.